Management of patients with peripheral arterial disease in primary care: a cross-sectional study in Germany
- PMID: 20584220
- DOI: 10.1111/j.1742-1241.2010.02337.x
Management of patients with peripheral arterial disease in primary care: a cross-sectional study in Germany
Abstract
Background: Studies in the primary care setting are of high interest for assessing the management situation of patients with manifestations of atherothrombosis.
Aims: Therefore, we documented diagnostic procedures, characteristics, and management of patients with symptomatic and asymptomatic peripheral arterial disease (PAD).
Materials & methods: Prospective cross-sectional study in primary care practices throughout Germany.
Results: A total of 671 patients with newly diagnosed PAD were included (mean age 69.1 years; 62.1% men). Cardiovascular risk factors were highly prevalent in the total PAD group: arterial hypertension in 84.2%, hyperlipidaemia in 75.5%, present smoking in 45.0% and diabetes mellitus in 47.3%. Atherothrombotic comorbidities were also frequent: coronary artery disease in 44.9% and cerebrovascular disease in 28.1%. For confirmation of diagnosis, patients were referred to specialists in 66.9% of cases. Overall, ankle brachial index was measured in 89.0%, and a clinical PAD score assessed in 66.6% (agreement of both measures with Cohen's kappa only, kappa = 0.039; p = 0.209). Drug treatment of risk factors (as secondary prophylaxis) in line with current guidelines was reported in a high percentage of patients: 88.6% with any antiplatelet drug, 69.3% with statins, 62.4% with angiotensin converting enzyme inhibitors, 23.5% with AT(1) receptor blockers and 43.9% with beta-blockers. Between asymptomatic and symptomatic PAD, differences in the risk factor/comorbidity profiles were small; however, the latter group received intensified treatment.
Conclusion: Our findings confirm that patients with PAD pose a substantial challenge to physicians because of their high number of comorbidities. Compared with previous studies, management of such patients appears to have improved.
Comment in
-
Peripheral artery disease: appreciating the asymptomatic - yet lethal - epidemic.Int J Clin Pract. 2010 Jun;64(7):832-5. doi: 10.1111/j.1742-1241.2010.02393.x. Int J Clin Pract. 2010. PMID: 20584214 No abstract available.
Similar articles
-
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.Am Heart J. 2004 Aug;148(2):263-8. doi: 10.1016/j.ahj.2004.03.028. Am Heart J. 2004. PMID: 15308995 Clinical Trial.
-
Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?Eur J Cardiovasc Prev Rehabil. 2011 Apr;18(2):254-61. doi: 10.1177/1741826710389368. Epub 2011 Jan 28. Eur J Cardiovasc Prev Rehabil. 2011. PMID: 21450673
-
Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in Europe.Eur J Cardiovasc Prev Rehabil. 2011 Apr;18(2):270-7. doi: 10.1097/HJR.0b013e32833cca34. Eur J Cardiovasc Prev Rehabil. 2011. PMID: 20606595
-
Antiplatelet agents and arterial thrombosis.Clin Geriatr Med. 2006 Feb;22(1):57-74, viii. doi: 10.1016/j.cger.2005.09.002. Clin Geriatr Med. 2006. PMID: 16377467 Review.
-
Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus.Minerva Cardioangiol. 2011 Feb;59(1):101-8. Minerva Cardioangiol. 2011. PMID: 21285935 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials